| abstract |
The present invention provides an immune adjuvant having an action mechanism that induces the production of Th1-type cytokines. An immunoadjuvant comprising a soluble lignin polymer, producing no allergy-related factor, and characterized by induction of T helper 1 (Th1) type cytokines and increased expression of major histocompatibility antigen (MHC) class II molecules. [Selection figure] None |